ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #6,800Hybrid

Journal of Hepatocellular Carcinoma

Abbreviation (ISO):J HEPATOCELL CARCINO
•
Identifier (ISSN):2253-5969(Print)
•
Publisher:DOVE MEDICAL PRESS LTD
Clarivate IF (2026)
3.9↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Journal of Hepatocellular Carcinoma

WoS Q2
24684.6620205.8320214.9620224.120234.220243.420253.92026
Annual Impact Factor Metric
Current (2026):3.9
Scopus SJR & RankScopus Q2
0.809
#6,800

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
17

17 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate7.1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
119articles/year
99.65% Gold OA•79.17% Original Research

Aims & Scope

Journal of Hepatocellular Carcinoma (abbr: J HEPATOCELL CARCINO, ISSN: 2253-5969) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by DOVE MEDICAL PRESS LTD in New Zealand. The periodical holds a Journal Impact Factor (JIF) of 3.90, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.809 (Q2), an H-index of 17.

Topics Covered (Recognized by AI)
Medicine93%Biology92.2%Internal medicine91.9%Genetics91.6%Cancer research89.9%Hepatocellular carcinoma86.8%Pathology57.4%Surgery47.9%Oncology45.9%Cancer42.9%Gastroenterology42.3%Chemistry39.5%Immunology35.9%Biochemistry34.7%Mathematics30.8%Statistics29.1%Gene22.1%Radiology22.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q2
Rank120/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q2
Rank129/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.9
Articles / Year215
Total Citations29
2025
IF3.4
Articles / Year219
Total Citations586
2024
IF4.2
Articles / Year182
Total Citations1,184
2023
IF4.1
Articles / Year175
Total Citations1,949
2022
IF4.962
Articles / Year101
Total Citations1,430

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,800Scopus Q2SCImago Profile
Scopus Coverage:2019, 2021-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.809

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.63

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,174 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,287
3-Year Documents355
Citable Documents350

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate38.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HepatologyQ2
OncologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 7.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Hepatocellular Carcinoma (abbr: J HEPATOCELL CARCINO, ISSN: 2253-5969) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by DOVE MEDICAL PRESS LTD in New Zealand. The periodical holds a Journal Impact Factor (JIF) of 3.90, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.809 (Q2), an H-index of 17.

The journal enforces rigorous peer evaluation with an annual output of approximately 119 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,174 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
DOVE MEDICAL PRESS LTD
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEDOAJPubMed
Editorial Address
PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 32d64bef-0e17-4d9b-8a36-4aa82bf6c9f7
Database Updated: 2026-10-01